Evidence map›Paper›PMID 40700161›Full record

ReviewJournal of xenobiotics2025

Aspartame and Human Health: A Mini-Review of Carcinogenic and Systemic Effects.

Nour El Doueihy, Joya Ghaleb, Karl Kfoury, Katy Kaleen Khouzami, Nicolas Nassif, Philippe Attieh, Hilda E Ghadieh, Sami Azar, Amjad Kanaan, Frederic Harb

Abstract readReview
In one paragraph

Review in Journal of xenobiotics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nour El DoueihyFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli P.O. Box 100, Lebanon.
Joya GhalebFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli P.O. Box 100, Lebanon.
Karl KfouryFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli P.O. Box 100, Lebanon.
Katy Kaleen KhouzamiFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli P.O. Box 100, Lebanon.ORCID 0009-0001-6151-4182
Nicolas NassifFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli P.O. Box 100, Lebanon.ORCID 0009-0000-3526-6165
Philippe AttiehFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli P.O. Box 100, Lebanon.ORCID 0009-0006-8491-0790
Hilda E GhadiehFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli P.O. Box 100, Lebanon.
Sami AzarFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli P.O. Box 100, Lebanon.
Amjad KanaanFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli P.O. Box 100, Lebanon.
Frederic HarbFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli P.O. Box 100, Lebanon.ORCID 0000-0001-5882-1619

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aspartame, a widely used artificial sweetener, has been at the center of ongoing debates concerning its safety, particularly its potential role in cancer development. This review provides an overview and analysis of the current research exploring the carcinogenic effects of aspartame. It examines findings from in vitro studies, in vivo experiments, and epidemiological investigations to offer a comprehensive perspective on the controversy. The results from these studies remain inconsistent-some suggest a possible association between high aspartame intake and increased cancer risk, while others fail to establish a conclusive link. Additionally, this review explores potential mechanisms by which aspartame could exert carcinogenic effects, focusing on its metabolic byproducts and their influence on cellular and molecular processes. Despite these investigations, the question of aspartame's safety remains unresolved. Continued research is essential to clarify its role in cancer risk and to inform evidence-based dietary guidelines.

Indexed as

artificial sweetenersaspartamecancer riskcarcinogenicityformaldehyde metabolismlipid peroxidationoxidative stress

Identifiers

PMID40700161
PMCPMC12286081

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.